235 related articles for article (PubMed ID: 34213531)
21. VEXAS syndrome: lessons learnt from an early Australian case series.
Islam S; Cullen T; Sumpton D; Damodaran A; Heath D; Bosco A; Doo NW; Kidson-Gerber G; Cheong A; Lawford R; Walsh R; Sammel A
Intern Med J; 2022 Apr; 52(4):658-662. PubMed ID: 35419965
[TBL] [Abstract][Full Text] [Related]
22. VEXAS syndrome.
Grayson PC; Patel BA; Young NS
Blood; 2021 Jul; 137(26):3591-3594. PubMed ID: 33971000
[TBL] [Abstract][Full Text] [Related]
23. VEXAS within the spectrum of rheumatologic disease.
Koster MJ; Warrington KJ
Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
[TBL] [Abstract][Full Text] [Related]
24. Chronic recurrent multifocal osteomyelitis and deficiency of interleukin-1-receptor antagonist.
Sakran W; Shalev SA; Sakran W; Shalev SA; El-Shanti H; Uziel Y; Uziel Y
Pediatr Infect Dis J; 2013 Jan; 32(1):94. PubMed ID: 23241992
[No Abstract] [Full Text] [Related]
25. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
26. [News about autoinflammatory syndromes].
Blank N; Lorenz HM
Dtsch Med Wochenschr; 2015 Feb; 140(3):191-3. PubMed ID: 25658407
[No Abstract] [Full Text] [Related]
27. Therapeutic options in VEXAS syndrome: insights from a retrospective series.
Bourbon E; Heiblig M; Gerfaud Valentin M; Barba T; Durel CA; Lega JC; Barraco F; Sève P; Jamilloux Y; Sujobert P
Blood; 2021 Jul; 137(26):3682-3684. PubMed ID: 33619558
[No Abstract] [Full Text] [Related]
28. VEXAS: a vivid new syndrome associated with vacuoles in various hematopoietic cells.
Lytle A; Bagg A
Blood; 2021 Jul; 137(26):3690. PubMed ID: 34196684
[No Abstract] [Full Text] [Related]
29. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
[TBL] [Abstract][Full Text] [Related]
30. A case of VEXAS syndrome with subtle morphologic findings.
Horton RK; Zheng G
Blood; 2021 Oct; 138(15):1378. PubMed ID: 34647982
[No Abstract] [Full Text] [Related]
31. [Autoinflammatory diseases].
Grateau G
Rev Med Interne; 2018 Apr; 39(4):211-213. PubMed ID: 28139336
[No Abstract] [Full Text] [Related]
32. Novel somatic mutations in UBA1 as a cause of VEXAS syndrome.
Poulter JA; Collins JC; Cargo C; De Tute RM; Evans P; Ospina Cardona D; Bowen DT; Cunnington JR; Baguley E; Quinn M; Green M; McGonagle D; Beck DB; Werner A; Savic S
Blood; 2021 Jul; 137(26):3676-3681. PubMed ID: 33690815
[TBL] [Abstract][Full Text] [Related]
33. An Update on Autoinflammatory Diseases: Relopathies.
Steiner A; Harapas CR; Masters SL; Davidson S
Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
[TBL] [Abstract][Full Text] [Related]
35. [The laboratory approach in the diagnosis of systemic autoinflammatory diseases].
Cantarini L; Rigante D; Brizi MG; Sebastiani GD; Lucherini OM; Galeazzi M; Frediani B
Reumatismo; 2011; 63(2):101-10. PubMed ID: 21776447
[TBL] [Abstract][Full Text] [Related]
36. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
[TBL] [Abstract][Full Text] [Related]
37. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum.
Dehghan N; Marcon KM; Sedlic T; Beck DB; Dutz JP; Chen LYC
Lancet; 2021 Aug; 398(10300):621. PubMed ID: 34391501
[No Abstract] [Full Text] [Related]
38. Behçet's disease with a somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome.
Matsumoto H; Asano T; Tsuchida N; Maeda A; Yoshida S; Yokose K; Fujita Y; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Irie K; Norikawa N; Yamamoto T; Endo M; Fukuchi K; Ohkawara H; Ikezoe T; Uchiyama Y; Kirino Y; Matsumoto N; Watanabe H; Migita K
Clin Immunol; 2022 May; 238():108996. PubMed ID: 35398520
[No Abstract] [Full Text] [Related]
39. Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20).
Sato S; Fujita Y; Shigemura T; Matoba H; Agematsu K; Sumichika Y; Yashiro M; Ono A; Kawasaki Y; Kobayashi H; Watanabe H; Koga T; Kawakami A; Migita K
Arthritis Res Ther; 2018 Dec; 20(1):274. PubMed ID: 30526650
[No Abstract] [Full Text] [Related]
40. VEXAS syndrome: still expanding the clinical phenotype.
Oganesyan A; Jachiet V; Chasset F; Hirsch P; Hage-Sleiman M; Fabiani B; Duriez P; Georgin-Lavialle S; Delhommeau F; Hakobyan Y; Fain O; Mekinian A;
Rheumatology (Oxford); 2021 Sep; 60(9):e321-e323. PubMed ID: 33693570
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
